ABL Bio

About:

ABL Bio is a biotech research company that focuses on the development of therapeutic drugs for immuno-oncology diseases.

Website: https://www.ablbio.com/

Top Investors: IMM Investment, DSC Investment, Korea Investment Partners, DS Asset Management, Hana Financial Investment

Description:

ABL Bio is a biotech research company that focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Their core values are life-improvement, collaboration, innovation, and novel therapy.

Total Funding Amount:

$93.8M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Seongnam, Kyonggi-do, South Korea

Founded Date:

2016-01-01

Founders:

Sang Hoon Lee

Number of Employees:

51-100

Last Funding Date:

2023-09-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai